C1QTNF12 and metabolic dysfunction-associated steatotic liver disease: Dysregulation of CTRP12 has been shown be involved in the occurrence and development of cardiovascular and metabolic diseases, including coronary artery disease, heart failure, diabetes, obesity and non-alcoholic fatty liver disease.